Journal of Oncology

/ Table of Contents: 2009

Table of Contents

Table of Contents: 2009

Journal of Oncology -
Special Issue
Volume 2009
- Article ID 627840
- Research Article

Studies on Multifunctional Effect of All-Trans Retinoic Acid (ATRA) on Matrix Metalloproteinase-2 (MMP-2) and Its Regulatory Molecules in Human Breast Cancer Cells (MCF-7)

Anindita Dutta | Triparna Sen | ... | Amitava Chatterjee

Journal of Oncology -
Special Issue
- Volume 2009
- Article ID 896407
- Review Article

Improving Response Rates to EGFR-Targeted Therapies for Head and Neck Squamous Cell Carcinoma: Candidate Predictive Biomarkers and Combination Treatment with Src Inhibitors

Ann Marie Egloff | Jennifer Rubin Grandis

Journal of Oncology -
Special Issue
- Volume 2009
- Article ID 804108
- Review Article

Anti-EGFR-Targeted Therapy for Esophageal and Gastric Cancers: An Evolving Concept

Tomislav Dragovich | Christopher Campen

Journal of Oncology -
Special Issue
Volume 2009
- Article ID 693458
- Clinical Study

Estimation of Cachexia among Cancer Patients Based on Four Definitions

Kathleen M. Fox | John M. Brooks | ... | Chiun-Fang Chiou

Journal of Oncology -
Special Issue
Volume 2009
- Article ID 849051
- Review Article

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies

Monica Giovannini | Vanesa Gregorc | ... | Eugenio Villa

Journal of Oncology -
Special Issue
Volume 2009
- Article ID 106378
- Research Article

Cell Cycle Regulating Kinase Cdk4 as a Potential Target for Tumor Cell Treatment and Tumor Imaging

Franziska Graf | Lena Koehler | ... | Jens Pietzsch

Journal of Oncology -
Special Issue
Volume 2009
- Article ID 408038
- Research Article

Synergistic Induction of Apoptosis in Primary B-CLL Cells after Treatment with Recombinant Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand and Histone Deacetylase Inhibitors

Lyse A. Norian | Tamara A. Kucaba | ... | Thomas S. Griffith

Journal of Oncology -
Special Issue
- Volume 2009
- Article ID 814140
- Research Article

Response of Patient-Derived Non-Small Cell Lung Cancer Xenografts to Classical and Targeted Therapies Is Not Related to Multidrug Resistance Markers

Jana Rolff | Cornelia Dorn | ... | Iduna Fichtner

Journal of Oncology -
Special Issue
Volume 2009
- Article ID 596560
- Research Article

In Vivo Measurements of Tumor Metabolism and Growth after Administration of Enzastaurin Using Small Animal FDG Positron Emission Tomography

Karen E. Pollok | Michael Lahn | ... | Gary Hutchins

Journal of Oncology -
Special Issue
Volume 2009
- Article ID 876138
- Case Report

Postirradiation Osteosarcoma of the Maxilla: A Case Report and Current Review of Literature

Imene Chabchoub | Olfa Gharbi | ... | Slim Ben Ahmed

Journal of Oncology -
Special Issue
- Volume 2009
- Article ID 567486
- Review Article

Clinical Efficacy and Toxicity of Anti-EGFR Therapy in Common Cancers

Amir Harandi | Aisha S. Zaidi | ... | Damian A. Laber

Journal of Oncology -
Special Issue
Volume 2009
- Article ID 458528
- Research Article

A Population-Based Clinical Trial of Irinotecan and Carboplatin

Derick Lau | Minh Huynh | Jewel Johl

Journal of Oncology -
Special Issue
- Volume 2009
- Article ID 526963
- Review Article

Anti-EGFR Therapy: Mechanism and Advances in Clinical Efficacy in Breast Cancer

John F. Flynn | Christina Wong | Joseph M. Wu

Journal of Oncology -
Special Issue
- Volume 2009
- Article ID 967920
- Review Article

Update in Antiepidermal Growth Factor Receptor Therapy in the Management of Metastatic Colorectal Cancer

Herbert H. Loong | Brigette B. Ma | Anthony T. C. Chan

Journal of Oncology -
Special Issue
- Volume 2009
- Article ID 342391
- Review Article

TGF- 1-Induced Expression of the Poor Prognosis SERPINE1/PAI-1 Gene Requires EGFR Signaling: A New Target for Anti-EGFR Therapy

Rohan Samarakoon | Craig E. Higgins | ... | Paul J. Higgins

Evaluate your manuscript with the free Manuscript Language Checker

Author guidelines

Editorial board

Databases and indexing

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.